Leveraging topoisomerase II-mediated DNA damage: repurposing etoposide as a lead compound for apicomplexan parasite control.

Notably, hematological parameters including RBC count ( Figure 4a ), hemoglobin (HGB) concentration ( Figure 4b ), hematocrit (HCT) percentage ( Figure 4c ), and HGB count ( Figure 4d ), showed an increasing trend from days 12 to 20 in the EP-treated groups when compared to the untreated infected group.

also in 63,971 other papers